{
    "persona": "liberal",
    "model": "llama2:70b-chat-q6_K",
    "topic": "healthcare",
    "language": "English",
    "text": "Exciting news for migraine sufferers! New data shows atogepant 60 mg daily significantly reduces monthly migraine days by 50% for 70% of patients, with sustained efficacy over 48 weeks. Let's continue to push for more research and treatment options for those living with this debilitating condition.",
    "retrieved_source": "https://www.medscape.com/viewarticle/first-long-term-data-atogepant-migraine-prevention-2024a10007cb",
    "annotation": {
        "topic": null,
        "persona": null,
        "authenticity": null
    },
    "id": "f0b5b49b13b7710ae2a92e92757f51e15fe2f6a585a6780e"
}